Hip precautions after posterior-approach total hip arthroplasty among patients with primary hip osteoarthritis do not influence early recovery: a systematic review and meta-analysis of randomized and non-randomized studies with 8,835 patients.


Journal

Acta orthopaedica
ISSN: 1745-3682
Titre abrégé: Acta Orthop
Pays: Sweden
ID NLM: 101231512

Informations de publication

Date de publication:
05 04 2023
Historique:
received: 26 08 2022
medline: 12 4 2023
entrez: 11 4 2023
pubmed: 12 4 2023
Statut: epublish

Résumé

Hip precautions are routinely prescribed to patients with osteoarthritis to decrease dislocation rates after total hip arthroplasty (THA) using a posterior approach. However, recommendations have been based on very low certainty of evidence. We updated the evidence on the influence of hip precautions on early recovery following THA by this systematic review. We performed systematic searches for randomized controlled trials (RCT) and non-randomized (NRS) studies in MEDLINE, Embase, PEDro, and CINAHL published from 2016 to July 2022. 2 reviewers independently included studies comparing postoperative precautions with minimal or no precautions, extracted data, and assessed the risk of bias. Random effects meta-analyses were used to synthesize the results. The certainty of the evidence was rated by the Grading of Recommendations Assessment and Evaluation approach. The critical outcome was the risk of hip dislocations within 3 months of surgery. Other outcomes were long-term risk of dislocation and reoperation, self-reported and performance-based assessment of function, quality of life, pain, and time to return to work. 4 RCTs and 5 NRSs, including 8,835 participants, were included. There may be no or negligible difference in early hip dislocations (RCTs: risk ratio [RR] 1.8, 95% confidence interval [CI] 0.6-5.2; NRS: RR 0.9, CI 0.3-2.5). Certainty in the evidence was low for RCTs and very low for NRSs. Finally, precautions may reduce the performance-based assessment of function slightly, but the evidence was very uncertain. For all other outcomes, no differences were found (moderate to very low certainty evidence). The current evidence does not support routinely prescribing hip precautions post-surgically for patients undergoing THA to prevent hip dislocations. However, the results might change with high-quality studies.

Sections du résumé

BACKGROUND AND PURPOSE
Hip precautions are routinely prescribed to patients with osteoarthritis to decrease dislocation rates after total hip arthroplasty (THA) using a posterior approach. However, recommendations have been based on very low certainty of evidence. We updated the evidence on the influence of hip precautions on early recovery following THA by this systematic review.
MATERIALS AND METHODS
We performed systematic searches for randomized controlled trials (RCT) and non-randomized (NRS) studies in MEDLINE, Embase, PEDro, and CINAHL published from 2016 to July 2022. 2 reviewers independently included studies comparing postoperative precautions with minimal or no precautions, extracted data, and assessed the risk of bias. Random effects meta-analyses were used to synthesize the results. The certainty of the evidence was rated by the Grading of Recommendations Assessment and Evaluation approach. The critical outcome was the risk of hip dislocations within 3 months of surgery. Other outcomes were long-term risk of dislocation and reoperation, self-reported and performance-based assessment of function, quality of life, pain, and time to return to work.
RESULTS
4 RCTs and 5 NRSs, including 8,835 participants, were included. There may be no or negligible difference in early hip dislocations (RCTs: risk ratio [RR] 1.8, 95% confidence interval [CI] 0.6-5.2; NRS: RR 0.9, CI 0.3-2.5). Certainty in the evidence was low for RCTs and very low for NRSs. Finally, precautions may reduce the performance-based assessment of function slightly, but the evidence was very uncertain. For all other outcomes, no differences were found (moderate to very low certainty evidence).
CONCLUSION
The current evidence does not support routinely prescribing hip precautions post-surgically for patients undergoing THA to prevent hip dislocations. However, the results might change with high-quality studies.

Identifiants

pubmed: 37039064
doi: 10.2340/17453674.2023.11958
pmc: PMC10087740
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-151

Références

Stat Med. 2000 Nov 30;19(22):3127-31
pubmed: 11113947
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
Clin Orthop Relat Res. 2018 Dec;476(12):2432-2441
pubmed: 30179951
J Bone Joint Surg Am. 2021 Feb 17;103(4):295-302
pubmed: 33347013
Disabil Rehabil. 2021 Oct;43(20):2882-2889
pubmed: 32088992
J Arthroplasty. 2019 Oct;34(10):2415-2419
pubmed: 31248711
BMC Musculoskelet Disord. 2016 May 25;17:228
pubmed: 27225033
Clin Rehabil. 2016 Apr;30(4):329-39
pubmed: 25834275
Clin Rehabil. 2022 Jun;36(6):767-775
pubmed: 35167386
J Arthroplasty. 2019 Jul;34(7S):S221-S227.e1
pubmed: 30975478
BMC Musculoskelet Disord. 2003 May 30;4:10
pubmed: 12777182
Hip Int. 2018 Sep;28(5):485-490
pubmed: 29874940
Acta Orthop. 2019 Apr;90(2):143-147
pubmed: 30739539
J Clin Nurs. 2020 Feb;29(3-4):567-582
pubmed: 31769559
Disabil Rehabil. 2022 Dec;44(26):8303-8310
pubmed: 34932433
J Am Acad Orthop Surg. 2020 May 15;28(10):e440-e447
pubmed: 31567897
Arthroplasty. 2019 Sep 2;1(1):6
pubmed: 35240763
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Acta Orthop. 2020 Dec;91(6):687-692
pubmed: 32718213
Acta Orthop. 2022 Jan 03;93:29-36
pubmed: 34633915
J Arthroplasty. 2022 Aug;37(8S):S876-S880
pubmed: 35093547
Osteoarthritis Cartilage. 2013 Aug;21(8):1042-52
pubmed: 23680877
Eur J Phys Rehabil Med. 2014 Aug;50(4):383-93
pubmed: 24476806
Hip Int. 2019 Nov;29(6):572-577
pubmed: 30630364
Acta Orthop. 2015;86(4):463-8
pubmed: 25753456
Orthopedics. 2009 Dec;32(12):889
pubmed: 19968217
Cochrane Database Syst Rev. 2016 Jul 04;7:CD010815
pubmed: 27374001
J Clin Epidemiol. 2022 Feb;142:200-208
pubmed: 34800676
Clin Interv Aging. 2013;8:1569-77
pubmed: 24348026
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
Disabil Rehabil. 2021 Oct;43(20):2890-2896
pubmed: 32045541
Res Synth Methods. 2021 Jan;12(1):55-61
pubmed: 32336025
Lancet Rheumatol. 2019 Oct;1(2):e111-e121
pubmed: 35079707
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Acta Orthop. 2017 Jun;88(3):239-247
pubmed: 28464754
Acta Orthop. 2022 May 31;93:503-508
pubmed: 35642500
J Rheumatol. 2019 Aug;46(8):981-989
pubmed: 30647185
J Arthroplasty. 2020 Jun;35(6S):S246-S251
pubmed: 32146109
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Int J Orthop Trauma Nurs. 2018 Nov;31:13-19
pubmed: 30297138
J Arthroplasty. 2018 Oct;33(10):3201-3205
pubmed: 29958753
Acta Orthop. 2019 Oct;90(5):411-416
pubmed: 31060427
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
J Bone Joint Surg Am. 2005 Feb;87(2):247-53
pubmed: 15687143
Geriatr Orthop Surg Rehabil. 2015 Sep;6(3):230-5
pubmed: 26328242

Auteurs

Christoffer B Korfitsen (CB)

Danish Health Authority, Evidence-based Medicine, Copenhagen; Cochrane Denmark & Centre for Evidence-Based Medicine Odense (CEBMO), Department of Clinical Research, University of Southern Denmark; Open Patient Data Explorative Network (OPEN), Odense University Hospital, Odense. ckorfitsen@health.sdu.dk.

Lone R Mikkelsen (LR)

Department of Clinical Medicine, Aarhus University; Elective Surgery Centre, Silkeborg Regional Hospital.

Marie-Louise Mikkelsen (ML)

Danish Health Authority, Evidence-based Medicine, Copenhagen.

Jeanett F Rohde (JF)

Danish Health Authority, Evidence-based Medicine, Copenhagen; The Parker Institute, Bispebjerg and Frederiksberg Hospital, Capital Region, Frederiksberg.

Pætur M Holm (PM)

The Research Unit PROgrez, Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse- Ringsted Hospitals; The Research Unit for Musculoskeletal Function and Physiotherapy, University of Southern Denmark.

Simon Tarp (S)

Danish Health Authority, Evidence-based Medicine, Copenhagen.

Holger-Henning F Carlsen (HF)

Særslev Medical Center, Søndersø.

Kirsten Birkefoss (K)

Danish Health Authority, Evidence-based Medicine, Copenhagen.

Thomas Jakobsen (T)

Department of Orthopaedics, Aalborg University Hospital.

Erik Poulsen (E)

Department of Sports Science and Clinical Biomechanics, University of Southern Denmark.

Jane S Leonhardt (JS)

Department of Orthopedics, Lillebaelt Hospital, Vejle.

Søren Overgaard (S)

Department of Orthopaedic Surgery and Traumatology, Copenhagen University Hospital, Bispebjerg; University of Copenhagen, Department of Clinical Medicine, Faculty of Health and Medical Sciences.

Inger Mechlenburg (I)

Department of Clinical Medicine, Aarhus University; Department of Public Health, Aarhus University; Department of Orthopaedics, Aarhus University Hospital, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH